Doctor profile · Federal record
Dr. RANDY GRELLNER, DO
Family Medicine Physician (CMS: FAMILY PRACTICE) · CUSHING, OK
- NPI 1356364376
- Accepts Medicare
- MIPS 89.6 / 100 · 2023
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1025 E 2ND ST
CUSHING, OK 740234136
(918) 225-3627
fax (918) 225-1008
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- May 1, 2014
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207Q00000X — NUCC code
- State license (1)
- Oklahoma #3663
- Medicaid
- OK #100137700B
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1356364376. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
31,497
Distinct HCPCS
10
Medicare allowed
$272,937
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1071 |
Injection, testosterone cypionate, 1 mg | 23,216 | 33 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,670 | 144 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 1,380 | 18 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 848 | 396 | $118 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 817 | 374 | $84 | |
36415 |
Insertion of needle into vein for collection of blood sample | 619 | 367 | $8 | |
96372 |
Injection of drug or substance under skin or into muscle | 561 | 207 | $13 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 512 | 83 | $1 | |
J0696 |
Injection, ceftriaxone sodium, per 250 mg | 308 | 51 | $1 | |
G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 215 | 215 | $121 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 822. This provider delivers 38× the peer median.Open Payments
Industry payments received
All-time total
$1,412
Transactions
73
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $399.95 | |
| Otsuka America Pharmaceutical, Inc. | 12 | $160.37 | |
| GlaxoSmithKline, LLC. | 5 | $102.01 | |
| Lilly USA, LLC | 6 | $87.88 | |
| PFIZER INC. | 6 | $83.53 | |
| Sumitomo Pharma America, Inc. | 4 | $80.33 | |
| ABBVIE INC. | 4 | $76.31 | |
| Novo Nordisk Inc | 3 | $52.93 | |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48.11 | |
| Edwards Lifesciences Corporation | 1 | $39.12 | |
| Alkermes, Inc. | 2 | $33.25 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $33.06 | |
| Phathom Pharmaceuticals, Inc. | 2 | $31.10 | |
| Janssen Pharmaceuticals, Inc | 2 | $30.81 | |
| Axsome Therapeutics, Inc. | 2 | $29.75 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,893
Patients
958
Total drug cost
$53,829
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 411 | 100 | $6,047 |
| Atorvastatin Calcium | Generic | 380 | 97 | $5,554 |
| Pantoprazole Sodium | Generic | 355 | 74 | $5,724 |
| Gabapentin | Generic | 318 | 72 | $6,209 |
| Potassium Chloride | Generic | 306 | 66 | $6,073 |
| Lisinopril | Generic | 282 | 65 | $3,220 |
| Amlodipine Besylate | Generic | 239 | 64 | $2,157 |
| Omeprazole | Generic | 230 | 61 | $4,550 |
| Losartan Potassium | Generic | 227 | 51 | $2,607 |
| Hydrochlorothiazide | Generic | 219 | 68 | $741 |